Home›Companies›Biotech & Pharma›XiltriX

XiltriX North America, LLC

Lab equipment and environmental monitoring with live support for biotech and biopharma facilities.

Updated Nov 9, 2026·Latest SEC filing Aug 26, 2026·Suggest an edit

About XiltriX

XiltriX is a private company based in San Diego, California. It has reported $22,596,363 raised in seven offerings on Form D since May 2019. Its chief executive is Moises Eilemberg.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 13, 2026Aug 26, 2026$3,000,000fully sold20$150KEquityRule 506(b)Form D ↗
Nov 26, 2024Dec 9, 2024$2,110,653fully sold18$117KEquityRule 506(b)Form D ↗
Feb 8, 2024Feb 14, 2024$2,499,999fully sold18$138KEquityRule 506(b)Form D ↗
Jan 18, 2023Feb 1, 2023$2,760,711of $3.5M target15$184KEquityRule 506(b)Form D ↗
Nov 17, 2021Nov 29, 2021$3,750,000fully sold12$312KEquityRule 506(b)Form D ↗
Sep 22, 2020Sep 23, 2020$4,275,000fully sold10$427KEquityRule 506(b)Form D ↗
May 15, 2019May 24, 2019amended May 29, 2019$4,200,000fully sold11$381KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, seven offerings$22,596,363

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on XiltriX's Form D filed Aug 26, 2026.

Sources

  1. SECXiltriX North America, LLC Form D, filed May 24, 2019
  2. SECXiltriX North America, LLC filing history
  3. CompanyTerms of Use
  4. CompanyAbout Our Company